BCRX
BioCryst Pharmaceuticals Inc
Price:  
7.27 
USD
Volume:  
4,225,853.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX EV/EBITDA

-279.5%
Upside

As of 2024-07-18, the EV/EBITDA ratio of BioCryst Pharmaceuticals Inc (BCRX) is -25.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BCRX's latest enterprise value is 2,259.26 mil USD. BCRX's TTM EBITDA according to its financial statements is -88.25 mil USD. Dividing these 2 quantities gives us the above BCRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 17.0x - 23.0x 20.1x
Forward P/E multiples 21.9x - 24.4x 23.8x
Fair Price (13.02) - (13.49) (13.05)
Upside -279.2% - -285.6% -279.5%
7.27 USD
Stock Price
(13.05) USD
Fair Price

BCRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-18 -25.12
2024-07-17 -25.60
2024-07-16 -26.44
2024-07-15 -25.39
2024-07-12 -25.32
2024-07-11 -25.06
2024-07-10 -23.78
2024-07-09 -23.75
2024-07-08 -23.61
2024-07-05 -23.85
2024-07-03 -23.59
2024-07-02 -23.92
2024-07-01 -24.20
2024-06-28 -23.05
2024-06-27 -22.89
2024-06-26 -23.05
2024-06-25 -22.82
2024-06-24 -23.26
2024-06-21 -23.61
2024-06-20 -22.98
2024-06-18 -22.63
2024-06-17 -23.19
2024-06-14 -23.03
2024-06-13 -23.17
2024-06-12 -23.33
2024-06-11 -23.75
2024-06-10 -23.85
2024-06-07 -23.36
2024-06-06 -23.66
2024-06-05 -24.48
2024-06-04 -24.36
2024-06-03 -24.48
2024-05-31 -23.71
2024-05-30 -23.96
2024-05-29 -22.98
2024-05-28 -23.08
2024-05-24 -22.94
2024-05-23 -23.40
2024-05-22 -24.17
2024-05-21 -23.61
2024-05-20 -22.94
2024-05-17 -23.29
2024-05-16 -23.73
2024-05-15 -23.47
2024-05-14 -21.13
2024-05-13 -21.77
2024-05-10 -21.04
2024-05-09 -21.09
2024-05-08 -20.53
2024-05-07 -20.90